Flu‑shot fizzles: Contamination news, but Singapore’s calm
Picture this: a batch of influenza vaccines from Sanofi Pasteur in France had some mysterious “white” and “black” particles floating in the swirl. The news hit Hong Kong and Taiwan like a bad cold—yep, about 175 000 doses in Hong Kong and a whopping 518 000 doses in Taiwan ran the risk of being a bit rough around the edges.
Hong Kong’s dash for safety
- Hospital Authority halted all flu‑shot clinics and hospital wards.
- They plan a gentle return to services by Saturday.
- No patient complaints yet—so far, the shots have behaved.
Taiwan’s tale of the mysterious prescription
The Food & Drug Administration confirmed the flares—some doses had suspicious white and black spots, hinting they’re not the crystal-clear liquid labs hope for.
Singapore: “All clear!”
The Health Sciences Authority (HSA) told our confiding reporter that these worrisome batches never graced the local shelves. Singapore’s markets are still in the clean‑painted, all‑clear zone. No shops or clinics in the Lion City knew about these particular batches.
Sanofi’s pledge to fix the fumble
- The French maker says quality, safety, and efficacy remain top‑notch—nothing got compromised.
- They’re reaching out to all facilities that stocked the odd batch and will swap out the unsafe doses.
So, while Hong Kong and Taiwan face a slight hiccup, Singapore can take a breath: no flu‑shot fears, just the usual Seasonal vaccine plan and a healthy dose of caution.
